Detalhe da pesquisa
1.
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.
N Engl J Med;
384(19): 1800-1809, 2021 05 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33979488
2.
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
Respir Res;
21(1): 264, 2020 Oct 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33050928
3.
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
Respir Res;
21(1): 266, 2020 Oct 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33050934
4.
A randomised, single-blind, single-dose, three-arm, parallel-group study in healthy subjects to demonstrate pharmacokinetic equivalence of ABP 501 and adalimumab.
Ann Rheum Dis;
76(3): 526-533, 2017 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27466231
5.
Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study.
Ann Rheum Dis;
76(10): 1679-1687, 2017 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28584187
6.
Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study.
J Am Acad Dermatol;
76(6): 1093-1102, 2017 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28291552
7.
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study.
Lancet Respir Med;
10(7): 650-660, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35364018
8.
Infiltration of histiocytes and multinucleated giant cells in the myocardium of a patient with multicentric reticulohistiocytosis.
J Clin Rheumatol;
15(1): 25-6, 2009 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18679136
9.
Histological evaluation of liver in two rheumatoid arthritis patients with chronic hepatitis B and C treated with TNF-alpha blockade: case reports.
Clin Rheumatol;
27(8): 1069-71, 2008 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18521652
10.
Effects of methotrexate use in a patient with rheumatoid arthritis and multiple sclerosis.
J Clin Rheumatol;
14(4): 241-2, 2008 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18766127
11.
Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community.
BioDrugs;
31(3): 175-187, 2017 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28439817
12.
Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators.
J Med Econ;
20(7): 703-714, 2017 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28294642
13.
Microscopic polyangiitis presenting as early cardiac tamponade.
J Clin Rheumatol;
16(2): 86-7, 2010 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20130479
14.
Influence of patient perceptions and preferences for osteoporosis medication on adherence behavior in the Denosumab Adherence Preference Satisfaction study.
Menopause;
21(1): 25-32, 2014 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23676636
15.
Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients.
Clin Rheumatol;
28(7): 787-91, 2009 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19291350
16.
Successful etanercept use in an HIV-positive patient with rheumatoid arthritis.
J Clin Rheumatol;
13(2): 79-80, 2007 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17414534
17.
Rosai-Dorfman disease in a patient with systemic lupus erythematosus.
J Rheumatol;
32(5): 951-3, 2005 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15868635
18.
Septic arthritis caused by Actinobacillus ureae in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha therapy.
J Rheumatol;
31(8): 1663-5, 2004 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15290751